Furthermore, similar to RBM47, FOXA1 expression was lowest in the CMS4 CRC subtype (Fig. 2e) and low FOXA1 expression was consistently associated with low relapse-free survival in CRC patients (Fig. 2f). Here, FOXA1 is linked to colorectal carcinoma.